D Damico Selected Research

carbobenzoxy-leucyl-leucyl-norvalinal

1/2001

Esomeprazole once daily for 6 months is effective therapy for maintaining healed erosive esophagitis and for controlling gastroesophageal reflux disease symptoms: a randomized, double-blind, placebo-controlled study of efficacy and safety.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

D Damico Research Topics

Disease

1	Esophagitis 01/2001
1	Gastroesophageal Reflux (GERD) 01/2001
1	Heartburn (Pyrosis) 01/2001
1	Headache Disorders (Headache Syndromes) 11/2000

Drug/Important Bio-Agent (IBA)

1	Esomeprazole (Nexium)FDA Link 01/2001
1	Proton Pump InhibitorsIBA 01/2001
1	carbobenzoxy-leucyl-leucyl-norvalinalIBA 01/2001
1	Omeprazole (Prilosec)FDA LinkGeneric 01/2001
1	Lamotrigine (Lamictal)FDA LinkGeneric 11/2000

Therapy/Procedure

1	Therapeutics 01/2001